Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +17.86% | -.--% | +9.27% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OREXO AB | Specialty & Advanced Pharmaceuticals | +17.86% | -.--% | +9.27% | +69.75% | -78.43% | 65.41M | - | - | - |
- Stock Market
- Equities
- ORX Stock
- ORXOY Stock
- Charts Orexo AB
- Relative Strength Chart